Life Sciences Tools and Services
Company Overview of DSM Biomedical B.V.
DSM Biomedical B.V. operates as a life sciences and biomaterials sciences company. The company manufactures biomedical materials for short and long-term implantable medical devices. The company is based in Heerlen, the Netherlands. DSM Biomedical B.V. operates as a subsidiary of Royal DSM N.V.
Het Overloon 1
Heerlen, 6411 TE
31 464 76 35 20
31 464 76 35 63
Key Executives for DSM Biomedical B.V.
Compensation as of Fiscal Year 2016.
DSM Biomedical B.V. Key Developments
Royal DSM Appopints Eric Teutsch as President of DSM Biomedical
Feb 16 16
Royal DSM announced Mr. Eric Teutsch's appointment as President of DSM Biomedical effective 16 February 2016. Mr. Teutsch succeeds Mr. Gerard de Reuver who served as the company's interim president since November 2015. As president, Mr. Teutsch will oversee the strategic development and execution of DSM Biomedical's global activities. Under his leadership, DSM Biomedical will continue to strengthen existing technology platforms and will explore opportunities to form strategic partnerships that complement its activities in the medical device market.
DSM Partners with Vention Medical to Provide Single-Source Solution for Catheters and Coatings
Jan 27 16
DSM Biomedical announced a partnership with Vention Medical to provide customers who develop and manufacture coated medical devices with a single-source offering. The partnership offers customers the option to integrate the development, testing and application of DSM’s ComfortCoat® coating into the catheter manufacturing process, eliminating the need to transfer finished products to another supplier for development and coating application services. Medical device manufacturers continue to improve clinical outcomes while being pressured, like never before, to further reduce costs. This is best achieved by designing innovative products for manufacturing, reducing time to market, and leveraging an integrated and consolidated supply chain. DSM’s innovative ComfortCoat coating can help improve performance and patient comfort when applied to medical devices, such as catheters. ComfortCoat coating helps device navigation and mitigates risks of acute trauma to the patient. The collaboration with Vention Medical enables device manufacturers to seamlessly integrate the coating design and production into their devices – optimizing the design and manufacturing efficiency. DSM’s materials scientists and applications engineers will now start to work alongside Vention Medical’s device designers and operations personnel to produce coated catheters. This partnership now enables devices being designed, assembled, coated, and packaged under one single quality system and under one roof. In doing so, work in process is kept to a minimum, supply chain is streamlined, and quality control is optimized. This collaboration offers device manufacturers an unmatched level of service and expertise – from raw materials science and technology innovation to component and device manufacturing, to operations management. This collective and integrated supply chain, on a global manufacturing and sourcing platform, enables DSM and Vention Medical the capability of bringing significant efficiencies to medical device companies.
DSM Biomedical Receives FDA 510K Clearance for Dyneema Purity Radiopaque Cerclage Cable for Use in Orthopedic Trauma
Dec 8 15
DSM Biomedical announced that the U.S. Food and Drug Administration has cleared the Dyneema Purity Radiopaque Cerclage Cable for use in orthopedic trauma treatments, such as treatment of bone and spine fractures. The Dyneema Purity Radiopaque Cerclage Cable, the first device fully designed and developed by The company’s Polyethylenes Team to receive 510k clearance from the FDA, marks a milestone for the company. The company sought 510k clearance to support the company’s customers in bringing their medical devices for use in orthopedic trauma to market. The cerclage cable is made out of Dyneema Purity Radiopaque fiber, the only radiopaque ultra high molecular weight polyethylene medical fiber in the world. While there are currently other polymeric cerclage cables in the market, these are not radiopaque and therefore cannot be visualized during and after surgical intervention. Dyneema Purity Radiopaque fiber is 15 times stronger than steel while maintaining high pliability and increased flexibility, which may help lower the risk of bone damage. The fiber is biocompatible and chemically inert, which can help reduce tissue inflammation, irritation and complications associated with metal allergies. When using steel cables, both ends of the cable must be guided through a tensioning device, and once fixation is complete, no incremental adjustments are possible. Re-adjustment can only be accomplished by cutting the cable and starting all over again.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|